Comparative Pharmacology
Head-to-head clinical analysis: DEXASPORIN versus OTOBIOTIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXASPORIN versus OTOBIOTIC.
DEXASPORIN vs OTOBIOTIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
Otobiotic is a fixed-dose combination of ciprofloxacin (a fluoroquinolone antibiotic) and fluocinolone acetonide (a corticosteroid). Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial DNA replication inhibition and cell death. Fluocinolone acetonide suppresses inflammation by binding to glucocorticoid receptors, modulating gene expression, and reducing inflammatory mediators.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
Adults and children: 3-4 drops into the affected ear twice daily for 7 days. Shake well before use.
None Documented
None Documented
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
Terminal elimination half-life: 2-3 hours in patients with normal renal function; prolonged to 24-48 hours in anuria.
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Renal elimination of unchanged drug: 60-80%; biliary/fecal elimination: 10-20%; the remainder undergoes hepatic metabolism.
Category C
Category C
Corticosteroid/Antibiotic Combination
Otic Antibiotic/Corticosteroid